1	Health-care	_	JJ	_	_	2	NMOD	_	_
2	companies	_	NNS	_	_	3	SBJ	_	_
3	should	_	MD	_	_	0	ROOT	_	_
4	get	_	VB	_	_	3	VC	_	_
5	healthier	_	RBR	_	_	4	PRD	_	_
6	in	_	IN	_	_	4	TMP	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	third	_	JJ	_	_	9	NMOD	_	_
9	quarter	_	NN	_	_	6	PMOD	_	_
10	.	_	.	_	_	3	P	_	_

1	Medical-supply	_	JJ	_	_	2	NMOD	_	_
2	houses	_	NNS	_	_	3	SBJ	_	_
3	are	_	VBP	_	_	30	OBJ	_	_
4	expected	_	VBN	_	_	3	VC	_	_
5	to	_	TO	_	_	4	OPRD	_	_
6	report	_	VB	_	_	5	IM	_	_
7	earnings	_	NNS	_	_	8	NMOD	_	_
8	increases	_	NNS	_	_	6	OBJ	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	about	_	RB	_	_	12	NMOD	_	_
11	15	_	CD	_	_	10	DEP	_	_
12	%	_	NN	_	_	9	PMOD	_	_
13	on	_	IN	_	_	12	NMOD	_	_
14	average	_	NN	_	_	13	PMOD	_	_
15	for	_	IN	_	_	8	NMOD	_	_
16	the	_	DT	_	_	18	NMOD	_	_
17	third	_	JJ	_	_	18	NMOD	_	_
18	quarter	_	NN	_	_	15	PMOD	_	_
19	,	_	,	_	_	4	P	_	_
20	despite	_	IN	_	_	4	ADV	_	_
21	sales	_	NNS	_	_	22	NMOD	_	_
22	increases	_	NNS	_	_	20	PMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	less	_	JJR	_	_	26	DEP	_	_
25	than	_	IN	_	_	26	DEP	_	_
26	10	_	CD	_	_	27	NMOD	_	_
27	%	_	NN	_	_	23	PMOD	_	_
28	,	_	,	_	_	30	P	_	_
29	analysts	_	NNS	_	_	30	SBJ	_	_
30	say	_	VBP	_	_	0	ROOT	_	_
31	.	_	.	_	_	30	P	_	_

1	To	_	TO	_	_	8	PRP	_	_
2	offset	_	VB	_	_	1	IM	_	_
3	sluggish	_	JJ	_	_	5	NMOD	_	_
4	sales	_	NNS	_	_	5	NMOD	_	_
5	growth	_	NN	_	_	2	OBJ	_	_
6	,	_	,	_	_	8	P	_	_
7	companies	_	NNS	_	_	8	SBJ	_	_
8	have	_	VBP	_	_	0	ROOT	_	_
9	been	_	VBN	_	_	8	VC	_	_
10	cutting	_	VBG	_	_	9	VC	_	_
11	staff	_	NN	_	_	10	OBJ	_	_
12	,	_	,	_	_	10	P	_	_
13	mostly	_	RB	_	_	14	PMOD	_	_
14	through	_	IN	_	_	10	ADV	_	_
15	attrition	_	NN	_	_	14	PMOD	_	_
16	,	_	,	_	_	10	P	_	_
17	and	_	CC	_	_	10	COORD	_	_
18	slowing	_	VBG	_	_	17	CONJ	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	growth	_	NN	_	_	18	OBJ	_	_
21	in	_	IN	_	_	20	LOC	_	_
22	research	_	NN	_	_	21	PMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	development	_	NN	_	_	25	NMOD	_	_
25	spending	_	NN	_	_	23	CONJ	_	_
26	.	_	.	_	_	8	P	_	_

1	Sales	_	NNS	_	_	2	NMOD	_	_
2	growth	_	NN	_	_	6	SBJ	_	_
3	in	_	IN	_	_	2	TMP	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	quarter	_	NN	_	_	3	PMOD	_	_
6	was	_	VBD	_	_	0	ROOT	_	_
7	slowed	_	VBN	_	_	6	VC	_	_
8	by	_	IN	_	_	7	LGS	_	_
9	mounting	_	JJ	_	_	10	NMOD	_	_
10	pressure	_	NN	_	_	8	PMOD	_	_
11	from	_	IN	_	_	10	NMOD	_	_
12	groups	_	NNS	_	_	11	PMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	buyers	_	NNS	_	_	13	PMOD	_	_
15	,	_	,	_	_	12	P	_	_
16	such	_	JJ	_	_	17	DEP	_	_
17	as	_	IN	_	_	12	NMOD	_	_
18	hospitals	_	NNS	_	_	17	PMOD	_	_
19	,	_	,	_	_	10	P	_	_
20	to	_	TO	_	_	10	NMOD	_	_
21	hold	_	VB	_	_	20	IM	_	_
22	down	_	RP	_	_	21	PRT	_	_
23	prices	_	NNS	_	_	21	OBJ	_	_
24	.	_	.	_	_	6	P	_	_

1	Suppliers	_	NNS	_	_	2	SBJ	_	_
2	were	_	VBD	_	_	0	ROOT	_	_
3	also	_	RB	_	_	2	ADV	_	_
4	hurt	_	VBN	_	_	2	VC	_	_
5	by	_	IN	_	_	4	LGS	_	_
6	the	_	DT	_	_	9	NMOD	_	_
7	stronger	_	JJR	_	_	9	NMOD	_	_
8	U.S.	_	NNP	_	_	9	NMOD	_	_
9	dollar	_	NN	_	_	5	PMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	which	_	WDT	_	_	12	SBJ	_	_
12	makes	_	VBZ	_	_	9	NMOD	_	_
13	sales	_	NNS	_	_	12	OBJ	_	_
14	abroad	_	RB	_	_	13	LOC	_	_
15	more	_	RBR	_	_	16	AMOD	_	_
16	difficult	_	JJ	_	_	12	OPRD	_	_
17	.	_	.	_	_	2	P	_	_

1	In	_	IN	_	_	6	LOC	_	_
2	some	_	DT	_	_	3	NMOD	_	_
3	cases	_	NNS	_	_	1	PMOD	_	_
4	,	_	,	_	_	6	P	_	_
5	competition	_	NN	_	_	6	SBJ	_	_
6	has	_	VBZ	_	_	0	ROOT	_	_
7	squeezed	_	VBN	_	_	6	VC	_	_
8	margins	_	NNS	_	_	7	OBJ	_	_
9	.	_	.	_	_	6	P	_	_

1	Becton	_	NNP	_	_	10	SBJ	_	_
2	,	_	,	_	_	1	P	_	_
3	Dickinson	_	NNP	_	_	1	COORD	_	_
4	&	_	CC	_	_	3	COORD	_	_
5	Co.	_	NNP	_	_	4	CONJ	_	_
6	,	_	,	_	_	10	P	_	_
7	for	_	IN	_	_	10	ADV	_	_
8	example	_	NN	_	_	7	PMOD	_	_
9	,	_	,	_	_	10	P	_	_
10	faces	_	VBZ	_	_	0	ROOT	_	_
11	stiff	_	JJ	_	_	12	NMOD	_	_
12	competition	_	NN	_	_	10	OBJ	_	_
13	from	_	IN	_	_	12	NMOD	_	_
14	a	_	DT	_	_	16	NMOD	_	_
15	Japanese	_	JJ	_	_	16	NMOD	_	_
16	supplier	_	NN	_	_	13	PMOD	_	_
17	in	_	IN	_	_	12	LOC	_	_
18	the	_	DT	_	_	21	NMOD	_	_
19	important	_	JJ	_	_	21	NMOD	_	_
20	syringe	_	NN	_	_	21	NMOD	_	_
21	market	_	NN	_	_	17	PMOD	_	_
22	.	_	.	_	_	10	P	_	_

1	The	_	DT	_	_	7	NMOD	_	_
2	Franklin	_	NNP	_	_	5	NAME	_	_
3	Lakes	_	NNP	_	_	5	NAME	_	_
4	,	_	,	_	_	5	P	_	_
5	N.J.	_	NNP	_	_	7	LOC	_	_
6	,	_	,	_	_	5	P	_	_
7	company	_	NN	_	_	8	SBJ	_	_
8	is	_	VBZ	_	_	32	OBJ	_	_
9	expected	_	VBN	_	_	8	VC	_	_
10	to	_	TO	_	_	9	OPRD	_	_
11	report	_	VB	_	_	10	IM	_	_
12	sales	_	JJ	_	_	13	NMOD	_	_
13	growth	_	NN	_	_	11	OBJ	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	only	_	JJ	_	_	20	DEP	_	_
16	5	_	CD	_	_	20	DEP	_	_
17	%	_	NN	_	_	20	DEP	_	_
18	to	_	TO	_	_	20	DEP	_	_
19	6	_	CD	_	_	20	DEP	_	_
20	%	_	NN	_	_	14	PMOD	_	_
21	,	_	,	_	_	8	P	_	_
22	but	_	CC	_	_	8	COORD	_	_
23	should	_	MD	_	_	22	CONJ	_	_
24	still	_	RB	_	_	23	TMP	_	_
25	maintain	_	VB	_	_	23	VC	_	_
26	earnings	_	NNS	_	_	27	NMOD	_	_
27	growth	_	NN	_	_	25	OBJ	_	_
28	of	_	IN	_	_	27	NMOD	_	_
29	10	_	CD	_	_	30	NMOD	_	_
30	%	_	NN	_	_	28	PMOD	_	_
31	,	_	,	_	_	32	P	_	_
32	says	_	VBZ	_	_	0	ROOT	_	_
33	Jerry	_	NNP	_	_	35	NAME	_	_
34	E.	_	NNP	_	_	35	NAME	_	_
35	Fuller	_	NNP	_	_	32	SBJ	_	_
36	,	_	,	_	_	35	P	_	_
37	an	_	DT	_	_	38	NMOD	_	_
38	analyst	_	NN	_	_	35	APPO	_	_
39	with	_	IN	_	_	38	NMOD	_	_
40	Duff	_	NNP	_	_	39	PMOD	_	_
41	&	_	CC	_	_	40	COORD	_	_
42	Phelps	_	NNP	_	_	41	CONJ	_	_
43	Inc	_	NNP	_	_	42	POSTHON	_	_
44	.	_	.	_	_	32	P	_	_

1	Among	_	IN	_	_	13	ADV	_	_
2	the	_	DT	_	_	3	NMOD	_	_
3	first	_	JJ	_	_	1	PMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	group	_	NN	_	_	4	PMOD	_	_
7	to	_	TO	_	_	3	NMOD	_	_
8	post	_	VB	_	_	7	IM	_	_
9	results	_	NNS	_	_	8	OBJ	_	_
10	,	_	,	_	_	13	P	_	_
11	Abbott	_	NNP	_	_	12	NAME	_	_
12	Laboratories	_	NNP	_	_	13	SBJ	_	_
13	said	_	VBD	_	_	0	ROOT	_	_
14	third-quarter	_	JJ	_	_	16	NMOD	_	_
15	net	_	JJ	_	_	16	NMOD	_	_
16	income	_	NN	_	_	17	SBJ	_	_
17	jumped	_	VBD	_	_	13	OBJ	_	_
18	14	_	CD	_	_	19	NMOD	_	_
19	%	_	NN	_	_	17	EXT	_	_
20	to	_	TO	_	_	17	DIR	_	_
21	$	_	$	_	_	20	PMOD	_	_
22	196	_	CD	_	_	21	DEP	_	_
23	million	_	CD	_	_	21	DEP	_	_
24	,	_	,	_	_	21	P	_	_
25	or	_	CC	_	_	21	COORD	_	_
26	88	_	CD	_	_	27	NMOD	_	_
27	cents	_	NNS	_	_	25	CONJ	_	_
28	a	_	DT	_	_	29	NMOD	_	_
29	share	_	NN	_	_	27	ADV	_	_
30	,	_	,	_	_	17	P	_	_
31	from	_	IN	_	_	17	DIR	_	_
32	$	_	$	_	_	31	PMOD	_	_
33	172	_	CD	_	_	32	DEP	_	_
34	million	_	CD	_	_	32	DEP	_	_
35	,	_	,	_	_	32	P	_	_
36	or	_	CC	_	_	32	COORD	_	_
37	76	_	CD	_	_	38	NMOD	_	_
38	cents	_	NNS	_	_	36	CONJ	_	_
39	a	_	DT	_	_	40	NMOD	_	_
40	share	_	NN	_	_	38	ADV	_	_
41	,	_	,	_	_	32	P	_	_
42	a	_	DT	_	_	43	NMOD	_	_
43	year	_	NN	_	_	44	AMOD	_	_
44	earlier	_	RBR	_	_	31	TMP	_	_
45	.	_	.	_	_	13	P	_	_

1	Sales	_	NNS	_	_	13	SBJ	_	_
2	for	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	company	_	NN	_	_	2	PMOD	_	_
5	,	_	,	_	_	4	P	_	_
6	based	_	VBN	_	_	4	APPO	_	_
7	in	_	IN	_	_	6	LOC	_	_
8	Abbott	_	NNP	_	_	9	NAME	_	_
9	Park	_	NNP	_	_	7	PMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	Ill.	_	NNP	_	_	9	APPO	_	_
12	,	_	,	_	_	9	P	_	_
13	rose	_	VBD	_	_	0	ROOT	_	_
14	8.3	_	CD	_	_	15	NMOD	_	_
15	%	_	NN	_	_	13	EXT	_	_
16	to	_	TO	_	_	13	DIR	_	_
17	$	_	$	_	_	16	PMOD	_	_
18	1.31	_	CD	_	_	17	DEP	_	_
19	billion	_	CD	_	_	17	DEP	_	_
20	from	_	IN	_	_	13	DIR	_	_
21	$	_	$	_	_	20	PMOD	_	_
22	1.21	_	CD	_	_	21	DEP	_	_
23	billion	_	CD	_	_	21	DEP	_	_
24	.	_	.	_	_	13	P	_	_

1	Baxter	_	NNP	_	_	2	NAME	_	_
2	International	_	NNP	_	_	5	SBJ	_	_
3	Inc.	_	NNP	_	_	2	POSTHON	_	_
4	yesterday	_	NN	_	_	5	TMP	_	_
5	reported	_	VBD	_	_	0	ROOT	_	_
6	net	_	JJ	_	_	7	SBJ	_	_
7	climbed	_	VBD	_	_	5	OBJ	_	_
8	20	_	CD	_	_	9	NMOD	_	_
9	%	_	NN	_	_	7	EXT	_	_
10	in	_	IN	_	_	7	TMP	_	_
11	the	_	DT	_	_	13	NMOD	_	_
12	third	_	JJ	_	_	13	NMOD	_	_
13	period	_	NN	_	_	10	PMOD	_	_
14	to	_	TO	_	_	7	DIR	_	_
15	$	_	$	_	_	14	PMOD	_	_
16	102	_	CD	_	_	15	DEP	_	_
17	million	_	CD	_	_	15	DEP	_	_
18	,	_	,	_	_	15	P	_	_
19	or	_	CC	_	_	15	COORD	_	_
20	34	_	CD	_	_	21	NMOD	_	_
21	cents	_	NNS	_	_	19	CONJ	_	_
22	a	_	DT	_	_	23	NMOD	_	_
23	share	_	NN	_	_	21	ADV	_	_
24	,	_	,	_	_	7	P	_	_
25	from	_	IN	_	_	7	DIR	_	_
26	$	_	$	_	_	25	PMOD	_	_
27	85	_	CD	_	_	26	DEP	_	_
28	million	_	CD	_	_	26	DEP	_	_
29	,	_	,	_	_	26	P	_	_
30	or	_	CC	_	_	26	COORD	_	_
31	28	_	CD	_	_	32	NMOD	_	_
32	cents	_	NNS	_	_	30	CONJ	_	_
33	a	_	DT	_	_	34	NMOD	_	_
34	share	_	NN	_	_	32	ADV	_	_
35	,	_	,	_	_	26	P	_	_
36	a	_	DT	_	_	37	NMOD	_	_
37	year	_	NN	_	_	38	AMOD	_	_
38	earlier	_	RBR	_	_	25	TMP	_	_
39	.	_	.	_	_	5	P	_	_

1	Sales	_	NNS	_	_	9	SBJ	_	_
2	for	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	8	NMOD	_	_
4	Deerfield	_	NNP	_	_	6	NAME	_	_
5	,	_	,	_	_	6	P	_	_
6	Ill.	_	NNP	_	_	8	LOC	_	_
7	,	_	,	_	_	6	P	_	_
8	company	_	NN	_	_	2	PMOD	_	_
9	rose	_	VBD	_	_	0	ROOT	_	_
10	5.8	_	CD	_	_	11	NMOD	_	_
11	%	_	NN	_	_	9	EXT	_	_
12	to	_	TO	_	_	9	DIR	_	_
13	$	_	$	_	_	12	PMOD	_	_
14	1.81	_	CD	_	_	13	DEP	_	_
15	billion	_	CD	_	_	13	DEP	_	_
16	from	_	IN	_	_	9	DIR	_	_
17	$	_	$	_	_	16	PMOD	_	_
18	1.71	_	CD	_	_	17	DEP	_	_
19	billion	_	CD	_	_	17	DEP	_	_
20	.	_	.	_	_	9	P	_	_

1	But	_	CC	_	_	5	DEP	_	_
2	not	_	RB	_	_	3	AMOD	_	_
3	every	_	DT	_	_	4	NMOD	_	_
4	company	_	NN	_	_	5	SBJ	_	_
5	expects	_	VBZ	_	_	0	ROOT	_	_
6	to	_	TO	_	_	5	OPRD	_	_
7	report	_	VB	_	_	6	IM	_	_
8	increased	_	VBN	_	_	9	NMOD	_	_
9	earnings	_	NNS	_	_	7	OBJ	_	_
10	.	_	.	_	_	5	P	_	_

1	C.R.	_	NNP	_	_	2	NAME	_	_
2	Bard	_	NNP	_	_	5	SBJ	_	_
3	Inc.	_	NNP	_	_	2	POSTHON	_	_
4	yesterday	_	NN	_	_	5	TMP	_	_
5	said	_	VBD	_	_	0	ROOT	_	_
6	third-quarter	_	JJ	_	_	7	NMOD	_	_
7	net	_	JJ	_	_	8	SBJ	_	_
8	plunged	_	VBD	_	_	5	OBJ	_	_
9	51	_	CD	_	_	10	NMOD	_	_
10	%	_	NN	_	_	8	EXT	_	_
11	to	_	TO	_	_	8	DIR	_	_
12	$	_	$	_	_	11	PMOD	_	_
13	9.9	_	CD	_	_	12	DEP	_	_
14	million	_	CD	_	_	12	DEP	_	_
15	,	_	,	_	_	12	P	_	_
16	or	_	CC	_	_	12	COORD	_	_
17	18	_	CD	_	_	18	NMOD	_	_
18	cents	_	NNS	_	_	16	CONJ	_	_
19	a	_	DT	_	_	20	NMOD	_	_
20	share	_	NN	_	_	18	ADV	_	_
21	,	_	,	_	_	8	P	_	_
22	from	_	IN	_	_	8	DIR	_	_
23	$	_	$	_	_	22	PMOD	_	_
24	20	_	CD	_	_	23	DEP	_	_
25	million	_	CD	_	_	23	DEP	_	_
26	,	_	,	_	_	23	P	_	_
27	or	_	CC	_	_	23	COORD	_	_
28	35	_	CD	_	_	29	NMOD	_	_
29	cents	_	NNS	_	_	27	CONJ	_	_
30	a	_	DT	_	_	31	NMOD	_	_
31	share	_	NN	_	_	29	ADV	_	_
32	,	_	,	_	_	23	P	_	_
33	a	_	DT	_	_	34	NMOD	_	_
34	year	_	NN	_	_	35	AMOD	_	_
35	earlier	_	RBR	_	_	22	TMP	_	_
36	.	_	.	_	_	5	P	_	_

1	Sales	_	NNS	_	_	2	SBJ	_	_
2	fell	_	VBD	_	_	0	ROOT	_	_
3	1.2	_	CD	_	_	4	NMOD	_	_
4	%	_	NN	_	_	2	EXT	_	_
5	to	_	TO	_	_	2	DIR	_	_
6	$	_	$	_	_	5	PMOD	_	_
7	190.1	_	CD	_	_	6	DEP	_	_
8	million	_	CD	_	_	6	DEP	_	_
9	from	_	IN	_	_	2	DIR	_	_
10	$	_	$	_	_	9	PMOD	_	_
11	192.5	_	CD	_	_	10	DEP	_	_
12	million	_	CD	_	_	10	DEP	_	_
13	.	_	.	_	_	2	P	_	_

1	The	_	DT	_	_	7	NMOD	_	_
2	Murray	_	NNP	_	_	5	NAME	_	_
3	Hill	_	NNP	_	_	5	NAME	_	_
4	,	_	,	_	_	5	P	_	_
5	N.J.	_	NNP	_	_	7	LOC	_	_
6	,	_	,	_	_	5	P	_	_
7	company	_	NN	_	_	8	SBJ	_	_
8	said	_	VBD	_	_	0	ROOT	_	_
9	full-year	_	JJ	_	_	10	NMOD	_	_
10	earnings	_	NNS	_	_	11	SBJ	_	_
11	may	_	MD	_	_	8	OBJ	_	_
12	be	_	VB	_	_	11	VC	_	_
13	off	_	JJ	_	_	12	PRD	_	_
14	33	_	CD	_	_	15	NMOD	_	_
15	cents	_	NNS	_	_	13	AMOD	_	_
16	a	_	DT	_	_	17	NMOD	_	_
17	share	_	NN	_	_	15	ADV	_	_
18	because	_	IN	_	_	12	PRP	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	company	_	NN	_	_	21	SBJ	_	_
21	removed	_	VBD	_	_	18	SUB	_	_
22	a	_	DT	_	_	23	NMOD	_	_
23	catheter	_	NN	_	_	21	OBJ	_	_
24	from	_	IN	_	_	21	ADV	_	_
25	the	_	DT	_	_	26	NMOD	_	_
26	market	_	NN	_	_	24	PMOD	_	_
27	.	_	.	_	_	8	P	_	_

1	In	_	IN	_	_	6	TMP	_	_
2	1988	_	CD	_	_	1	PMOD	_	_
3	,	_	,	_	_	6	P	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	company	_	NN	_	_	6	SBJ	_	_
6	earned	_	VBD	_	_	0	ROOT	_	_
7	$	_	$	_	_	6	OBJ	_	_
8	1.38	_	CD	_	_	7	NMOD	_	_
9	a	_	DT	_	_	10	NMOD	_	_
10	share	_	NN	_	_	7	ADV	_	_
11	.	_	.	_	_	6	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	Food	_	NNP	_	_	6	SBJ	_	_
3	and	_	CC	_	_	2	COORD	_	_
4	Drug	_	NNP	_	_	5	NAME	_	_
5	Administration	_	NNP	_	_	3	CONJ	_	_
6	had	_	VBD	_	_	0	ROOT	_	_
7	raised	_	VBN	_	_	6	VC	_	_
8	questions	_	NNS	_	_	7	OBJ	_	_
9	about	_	IN	_	_	8	NMOD	_	_
10	the	_	DT	_	_	11	NMOD	_	_
11	device	_	NN	_	_	13	NMOD	_	_
12	's	_	POS	_	_	11	SUFFIX	_	_
13	design	_	NN	_	_	9	PMOD	_	_
14	.	_	.	_	_	6	P	_	_

1	Some	_	DT	_	_	2	NMOD	_	_
2	analysts	_	NNS	_	_	3	SBJ	_	_
3	add	_	VBP	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	OBJ	_	_
5	third-party	_	JJ	_	_	6	NMOD	_	_
6	pressures	_	NNS	_	_	11	SBJ	_	_
7	to	_	TO	_	_	6	NMOD	_	_
8	reduce	_	VB	_	_	7	IM	_	_
9	health	_	NN	_	_	10	NMOD	_	_
10	costs	_	NNS	_	_	8	OBJ	_	_
11	will	_	MD	_	_	4	SUB	_	_
12	continue	_	VB	_	_	11	VC	_	_
13	to	_	TO	_	_	12	OPRD	_	_
14	bedevil	_	VB	_	_	13	IM	_	_
15	companies	_	NNS	_	_	18	NMOD	_	_
16	'	_	POS	_	_	15	SUFFIX	_	_
17	bottom	_	JJ	_	_	18	NMOD	_	_
18	lines	_	NNS	_	_	14	OBJ	_	_
19	.	_	.	_	_	3	P	_	_

1	Takeover	_	NN	_	_	2	NMOD	_	_
2	speculation	_	NN	_	_	13	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	which	_	WDT	_	_	5	SBJ	_	_
5	has	_	VBZ	_	_	2	NMOD	_	_
6	been	_	VBN	_	_	5	VC	_	_
7	buoying	_	VBG	_	_	6	VC	_	_
8	stocks	_	NNS	_	_	7	OBJ	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	supply	_	NN	_	_	11	NMOD	_	_
11	houses	_	NNS	_	_	9	PMOD	_	_
12	,	_	,	_	_	2	P	_	_
13	may	_	MD	_	_	17	OBJ	_	_
14	also	_	RB	_	_	13	ADV	_	_
15	ease	_	VB	_	_	13	VC	_	_
16	,	_	,	_	_	17	P	_	_
17	says	_	VBZ	_	_	0	ROOT	_	_
18	Peter	_	NNP	_	_	19	NAME	_	_
19	Sidoti	_	NNP	_	_	17	SBJ	_	_
20	,	_	,	_	_	19	P	_	_
21	an	_	DT	_	_	22	NMOD	_	_
22	analyst	_	NN	_	_	19	APPO	_	_
23	with	_	IN	_	_	22	NMOD	_	_
24	Drexel	_	NNP	_	_	26	NAME	_	_
25	Burnham	_	NNP	_	_	26	NAME	_	_
26	Lambert	_	NNP	_	_	23	PMOD	_	_
27	Inc	_	NNP	_	_	26	POSTHON	_	_
28	.	_	.	_	_	17	P	_	_

1	``	_	``	_	_	20	P	_	_
2	As	_	IN	_	_	7	TMP	_	_
3	that	_	DT	_	_	4	SBJ	_	_
4	wanes	_	VBZ	_	_	2	SUB	_	_
5	,	_	,	_	_	7	P	_	_
6	you	_	PRP	_	_	7	SBJ	_	_
7	're	_	VBP	_	_	20	OBJ	_	_
8	going	_	VBG	_	_	7	VC	_	_
9	to	_	TO	_	_	8	VC	_	_
10	see	_	VB	_	_	9	IM	_	_
11	the	_	DT	_	_	12	NMOD	_	_
12	stocks	_	NNS	_	_	10	OBJ	_	_
13	probably	_	RB	_	_	14	ADV	_	_
14	wane	_	VBP	_	_	10	OPRD	_	_
15	as	_	IN	_	_	16	AMOD	_	_
16	well	_	RB	_	_	14	ADV	_	_
17	,	_	,	_	_	20	P	_	_
18	''	_	''	_	_	20	P	_	_
19	he	_	PRP	_	_	20	SBJ	_	_
20	says	_	VBZ	_	_	0	ROOT	_	_
21	.	_	.	_	_	20	P	_	_

1	Hospitals	_	NNS	_	_	2	NMOD	_	_
2	companies	_	NNS	_	_	6	SBJ	_	_
3	,	_	,	_	_	6	P	_	_
4	meanwhile	_	RB	_	_	6	TMP	_	_
5	,	_	,	_	_	6	P	_	_
6	are	_	VBP	_	_	0	ROOT	_	_
7	reporting	_	VBG	_	_	6	VC	_	_
8	improved	_	VBN	_	_	9	NMOD	_	_
9	earnings	_	NNS	_	_	7	OBJ	_	_
10	.	_	.	_	_	6	P	_	_

1	Bolstered	_	VBN	_	_	18	ADV	_	_
2	by	_	IN	_	_	1	LGS	_	_
3	strong	_	JJ	_	_	4	NMOD	_	_
4	performances	_	NNS	_	_	2	PMOD	_	_
5	by	_	IN	_	_	4	NMOD	_	_
6	its	_	PRP$	_	_	8	NMOD	_	_
7	psychiatric	_	JJ	_	_	8	NMOD	_	_
8	hospitals	_	NNS	_	_	5	PMOD	_	_
9	,	_	,	_	_	18	P	_	_
10	National	_	NNP	_	_	12	NAME	_	_
11	Medical	_	NNP	_	_	12	NAME	_	_
12	Enterprises	_	NNP	_	_	18	SBJ	_	_
13	Inc.	_	NNP	_	_	12	POSTHON	_	_
14	,	_	,	_	_	12	P	_	_
15	Los	_	NNP	_	_	16	NAME	_	_
16	Angeles	_	NNP	_	_	12	LOC	_	_
17	,	_	,	_	_	12	P	_	_
18	reported	_	VBD	_	_	0	ROOT	_	_
19	net	_	JJ	_	_	20	NMOD	_	_
20	income	_	NN	_	_	18	OBJ	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	$	_	$	_	_	21	PMOD	_	_
23	50	_	CD	_	_	22	DEP	_	_
24	million	_	CD	_	_	22	DEP	_	_
25	,	_	,	_	_	22	P	_	_
26	or	_	CC	_	_	22	COORD	_	_
27	65	_	CD	_	_	28	NMOD	_	_
28	cents	_	NNS	_	_	26	CONJ	_	_
29	a	_	DT	_	_	30	NMOD	_	_
30	share	_	NN	_	_	28	ADV	_	_
31	,	_	,	_	_	20	P	_	_
32	for	_	IN	_	_	20	NMOD	_	_
33	the	_	DT	_	_	35	NMOD	_	_
34	first	_	JJ	_	_	35	NMOD	_	_
35	quarter	_	NN	_	_	32	PMOD	_	_
36	ended	_	VBN	_	_	35	APPO	_	_
37	Aug.	_	NNP	_	_	36	TMP	_	_
38	31	_	CD	_	_	37	NMOD	_	_
39	,	_	,	_	_	20	P	_	_
40	up	_	RB	_	_	22	NMOD	_	_
41	from	_	IN	_	_	40	AMOD	_	_
42	$	_	$	_	_	41	PMOD	_	_
43	41	_	CD	_	_	42	DEP	_	_
44	million	_	CD	_	_	42	DEP	_	_
45	,	_	,	_	_	42	P	_	_
46	or	_	CC	_	_	42	COORD	_	_
47	56	_	CD	_	_	48	NMOD	_	_
48	cents	_	NNS	_	_	46	CONJ	_	_
49	a	_	DT	_	_	50	NMOD	_	_
50	share	_	NN	_	_	48	ADV	_	_
51	,	_	,	_	_	42	P	_	_
52	a	_	DT	_	_	53	NMOD	_	_
53	year	_	NN	_	_	54	AMOD	_	_
54	earlier	_	RBR	_	_	41	TMP	_	_
55	.	_	.	_	_	18	P	_	_

1	Humana	_	NNP	_	_	9	SBJ	_	_
2	Inc.	_	NNP	_	_	1	POSTHON	_	_
3	,	_	,	_	_	1	P	_	_
4	Louisville	_	NNP	_	_	1	LOC	_	_
5	,	_	,	_	_	4	P	_	_
6	Ky.	_	NNP	_	_	4	APPO	_	_
7	,	_	,	_	_	1	P	_	_
8	also	_	RB	_	_	9	ADV	_	_
9	reported	_	VBD	_	_	0	ROOT	_	_
10	favorable	_	JJ	_	_	11	NMOD	_	_
11	results	_	NNS	_	_	9	OBJ	_	_
12	,	_	,	_	_	11	P	_	_
13	with	_	IN	_	_	11	NMOD	_	_
14	net	_	JJ	_	_	15	NMOD	_	_
15	income	_	NN	_	_	13	PMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	$	_	$	_	_	16	PMOD	_	_
18	66.7	_	CD	_	_	17	DEP	_	_
19	million	_	CD	_	_	17	DEP	_	_
20	,	_	,	_	_	17	P	_	_
21	or	_	CC	_	_	17	COORD	_	_
22	66	_	CD	_	_	23	NMOD	_	_
23	cents	_	NNS	_	_	21	CONJ	_	_
24	,	_	,	_	_	15	P	_	_
25	in	_	IN	_	_	15	TMP	_	_
26	the	_	DT	_	_	28	NMOD	_	_
27	fourth	_	JJ	_	_	28	NMOD	_	_
28	quarter	_	NN	_	_	25	PMOD	_	_
29	ended	_	VBN	_	_	28	APPO	_	_
30	Aug.	_	NNP	_	_	29	TMP	_	_
31	31	_	CD	_	_	30	NMOD	_	_
32	,	_	,	_	_	15	P	_	_
33	up	_	RB	_	_	17	NMOD	_	_
34	from	_	IN	_	_	33	AMOD	_	_
35	$	_	$	_	_	34	PMOD	_	_
36	58.2	_	CD	_	_	35	DEP	_	_
37	million	_	CD	_	_	35	DEP	_	_
38	,	_	,	_	_	35	P	_	_
39	or	_	CC	_	_	35	COORD	_	_
40	59	_	CD	_	_	41	NMOD	_	_
41	cents	_	NNS	_	_	39	CONJ	_	_
42	,	_	,	_	_	35	P	_	_
43	a	_	DT	_	_	44	NMOD	_	_
44	year	_	NN	_	_	45	AMOD	_	_
45	earlier	_	RBR	_	_	34	TMP	_	_
46	.	_	.	_	_	9	P	_	_

1	Analysts	_	NNS	_	_	2	SBJ	_	_
2	say	_	VBP	_	_	0	ROOT	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	handful	_	NN	_	_	13	SBJ	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	hospital	_	NN	_	_	7	NMOD	_	_
7	companies	_	NNS	_	_	5	PMOD	_	_
8	that	_	WDT	_	_	9	SBJ	_	_
9	are	_	VBP	_	_	4	NMOD	_	_
10	still	_	RB	_	_	9	TMP	_	_
11	publicly	_	RB	_	_	12	MNR	_	_
12	traded	_	VBN	_	_	9	VC	_	_
13	are	_	VBP	_	_	2	OBJ	_	_
14	benefiting	_	VBG	_	_	13	VC	_	_
15	from	_	IN	_	_	14	ADV	_	_
16	several	_	JJ	_	_	17	NMOD	_	_
17	trends	_	NNS	_	_	15	PMOD	_	_
18	.	_	.	_	_	2	P	_	_

1	Most	_	RBS	_	_	2	AMOD	_	_
2	important	_	JJ	_	_	7	ADV	_	_
3	,	_	,	_	_	7	P	_	_
4	hospital	_	NN	_	_	6	NMOD	_	_
5	admission	_	NN	_	_	6	NMOD	_	_
6	rates	_	NNS	_	_	7	SBJ	_	_
7	are	_	VBP	_	_	0	ROOT	_	_
8	stabilizing	_	VBG	_	_	7	VC	_	_
9	after	_	IN	_	_	8	TMP	_	_
10	several	_	JJ	_	_	11	NMOD	_	_
11	years	_	NNS	_	_	9	PMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	decline	_	NN	_	_	12	PMOD	_	_
14	.	_	.	_	_	7	P	_	_

1	Moreover	_	RB	_	_	4	ADV	_	_
2	,	_	,	_	_	4	P	_	_
3	companies	_	NNS	_	_	4	SBJ	_	_
4	have	_	VBP	_	_	0	ROOT	_	_
5	sold	_	VBN	_	_	4	VC	_	_
6	off	_	RP	_	_	5	PRT	_	_
7	many	_	JJ	_	_	5	OBJ	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	their	_	PRP$	_	_	13	NMOD	_	_
10	smaller	_	JJR	_	_	13	NMOD	_	_
11	,	_	,	_	_	13	P	_	_
12	less-profitable	_	JJ	_	_	13	NMOD	_	_
13	hospitals	_	NNS	_	_	8	PMOD	_	_
14	and	_	CC	_	_	4	COORD	_	_
15	have	_	VBP	_	_	14	CONJ	_	_
16	completed	_	VBN	_	_	15	VC	_	_
17	painful	_	JJ	_	_	18	NMOD	_	_
18	restructurings	_	NNS	_	_	16	OBJ	_	_
19	.	_	.	_	_	4	P	_	_

1	Humana	_	NNP	_	_	3	NMOD	_	_
2	's	_	POS	_	_	1	SUFFIX	_	_
3	revenues	_	NNS	_	_	8	SBJ	_	_
4	,	_	,	_	_	8	P	_	_
5	for	_	IN	_	_	8	ADV	_	_
6	example	_	NN	_	_	5	PMOD	_	_
7	,	_	,	_	_	8	P	_	_
8	are	_	VBP	_	_	0	ROOT	_	_
9	being	_	VBG	_	_	8	VC	_	_
10	boosted	_	VBN	_	_	9	VC	_	_
11	by	_	IN	_	_	10	LGS	_	_
12	large	_	JJ	_	_	13	NMOD	_	_
13	increases	_	NNS	_	_	11	PMOD	_	_
14	in	_	IN	_	_	13	LOC	_	_
15	enrollments	_	NNS	_	_	14	PMOD	_	_
16	in	_	IN	_	_	15	NMOD	_	_
17	the	_	DT	_	_	18	NMOD	_	_
18	company	_	NN	_	_	22	NMOD	_	_
19	's	_	POS	_	_	18	SUFFIX	_	_
20	health	_	NN	_	_	22	NMOD	_	_
21	maintenance	_	NN	_	_	22	NMOD	_	_
22	organizations	_	NNS	_	_	16	PMOD	_	_
23	.	_	.	_	_	8	P	_	_

1	Says	_	VBZ	_	_	0	ROOT	_	_
2	Todd	_	NNP	_	_	3	NAME	_	_
3	Richter	_	NNP	_	_	1	SBJ	_	_
4	,	_	,	_	_	3	P	_	_
5	an	_	DT	_	_	6	NMOD	_	_
6	analyst	_	NN	_	_	3	APPO	_	_
7	with	_	IN	_	_	6	NMOD	_	_
8	Dean	_	NNP	_	_	10	NAME	_	_
9	Witter	_	NNP	_	_	10	NAME	_	_
10	Reynolds	_	NNP	_	_	7	PMOD	_	_
11	:	_	:	_	_	1	P	_	_
12	``	_	``	_	_	1	P	_	_
13	The	_	DT	_	_	14	NMOD	_	_
14	shakeout	_	NN	_	_	20	SBJ	_	_
15	in	_	IN	_	_	14	LOC	_	_
16	the	_	DT	_	_	19	NMOD	_	_
17	publicly	_	RB	_	_	18	AMOD	_	_
18	traded	_	VBN	_	_	19	NMOD	_	_
19	companies	_	NNS	_	_	15	PMOD	_	_
20	is	_	VBZ	_	_	1	OBJ	_	_
21	over	_	RB	_	_	20	PRD	_	_
22	.	_	.	_	_	1	P	_	_

